Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

autologous tumor cell vaccine

Known as: AC vaccine, ATCV, Autologous Cell Vaccine 
A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
A xenogeneic melanoma-antigen-enhanced allogeneic tumor cell vaccine (ATCV) is an appealing strategy for anti-cancer… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
For active specific immunotherapy of cancer patients, we designed the autologous virus–modified tumor cell vaccine ATV-NDV. The… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 5
Highly Cited
2003
Highly Cited
2003
AIM To treat patients with stage I-IV malignant tumors of digestive tract using autologous tumor cell vaccine and NDV (Newcastle… Expand
Highly Cited
2002
Highly Cited
2002
PURPOSE A reason that the immune system may fail to reject tumors is that T cells encounter tumor antigen derived peptides on the… Expand
Highly Cited
2001
Highly Cited
2001
We performed three multi-institutional, prospectively randomized, controlled clinical trials, assessing the therapeutic effect of… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2000
Highly Cited
2000
PURPOSE A randomized phase III clinical trial of adjuvant active specific immunotherapy (ASI) with an autologous tumor cell… Expand
Highly Cited
1996
Highly Cited
1996
An active specific immunization (ASI) procedure with two types of autologous tumor cell vaccines (ATVs) is tested for adjuvant… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Highly Cited
1995
Highly Cited
1995
BACKGROUND Cancer cells of microscopic metastases can be envisaged as ideal constituents for the development of a genetically… Expand
Highly Cited
1993
Highly Cited
1993
Summary For active specific immunotherapy, autologous tumor cells grown in vitro may be a more appropriate source of tumor… Expand
Highly Cited
1991
Highly Cited
1991
Twenty-four patients with metastatic melanoma were treated with a novel form of active immunotherapy, autologous tumor cell… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3